CASR and plasma cell myeloma: Multiple myeloma cells can transfer miR135b to endothelial cells by exosomes, which directly inhibit factor-inhibitory hypoxia-inducible factor (FIH-1) and promote endothelial cell migration, proliferation and angiogenesis by the HIF-FIH signaling pathway [47].